Pure Global

Lactate Dehydrogenase2 - India CDSCO Medical Device Registration

Lactate Dehydrogenase2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000223_fa0d7112604d4bb8d4395443dbc6322d_fb29d4af6db8a4c60f89424e9d73f632. This device is marketed under the brand name ARCHTECT Total T4 Controls. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Lactate Dehydrogenase2
UID: IMP/MD/2018/000223_fa0d7112604d4bb8d4395443dbc6322d_fb29d4af6db8a4c60f89424e9d73f632

Brand Name

ARCHTECT Total T4 Controls

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Lactate Dehydrogenase2 assay is used for the quantitation of lactate dehydrogenase (ARCHTECT Total T4 Controls) in human serum or plasma on the Alinity c system

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing